PRODUCT INFORMATION
Description
CXCL9(74-103) is a cationic COOH-terminal peptide derived from the chemokine CXCL9. It demonstrates high glycosaminoglycan (GAG) binding affinity and competitively inhibits functional chemokines from interacting with GAGs. This action disrupts chemokine gradient formation and can suppress neutrophil migration in inflammatory models, making it a tool for studying GAG-chemokine interactions.
Molecular Weight
3661.40
Purity
> 95%
Formula
C₁₅₈H₂₉₅N₅₉O₄₀
Product Type
Targeting Peptide
Sequence
Lys-Lys-Lys-Gln-Lys-Asn-Gly-Lys-Lys-His-Gln-Lys-Lys-Lys-Val-Leu-Lys-Val-Arg-Lys-Ser-Gln-Arg-Ser-Arg-Gln-Lys-Lys-Thr-Thr
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA Targeting Peptide (CAT#: OLY-1025-YS-51)
- CREKA Targeting Peptide (CAT#: OLY-1025-YS-18)
- NGR Targeting Peptide (CAT#: OLY-1025-YS-38)
- LSD Targeting Peptide (CAT#: OLY-1025-YS-2)
- Tumor Targeted Pro-apoptotic Peptide (CAT#: OLY-1025-YS-48)
- FRα-targeting Peptide C7 (CAT#: OLY-1025-YS-13)
- CooP Targeting Peptide (CAT#: OLY-1025-YS-12)
- LinTT1 Targeting Peptide (CAT#: OLY-1025-YS-24)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.